B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies — Moritz F. Sinner (2014) | RDL Network
B-type natriuretic peptide and C-reactive protein in the prediction of atrial fibrillation risk: the CHARGE-AF Consortium of community-based cohort studies
Article 2014 en
Authors
MS
Moritz F. Sinner
KS
Katherine A. Stepas
CM
Carlee Moser
Abstract
1 min read
B-type natriuretic peptide, not CRP, substantially improved AF risk prediction beyond clinical factors in an independently replicated, heterogeneous population. B-type natriuretic peptide may serve as a benchmark to evaluate novel putative AF risk biomarkers.
Moritz F. Sinner, Bouwe P. Krijthe, Thor Aspelund, Katherine A. Stepas, Michael Pencina, Carlee Moser, Nona Sootodehnia, João D. Fontes, A. Cecile J.W. Janssens, Richard A. Kronmal, Jared W. Magnani, Alanna M. Chamberlain, Steven A. Lubitz, Renate B. Schnabel, Ramachandran S. Vasan, Thomas J. Wang, Sunil Agarwal, David D. McManus, Patrick T. Ellinor, Martin G. Larson, Gregory L. Burke, Albert Hofman, Daniel Levy, John S. Gottdiener, Stefan Kääb, David Couper, Elsayed Z. Soliman, Bruno H. Stricker, Vilmundur Guðnason, Susan R. Heckbert, Emelia Benjamin, Álvaro Alonso
José Miguel Rivera‐Caravaca, Francisco Marı́n, Juan A. Vílchez, Josefa Gálvez, María Asunción Esteve‐Pastor, Vicente Vicente, Professor Gregory Lip, Vanessa Roldán
Seung Yong Shin, Sang Jin Han, Jin Seok Kim, Sung Il Im, Jaemin Shim, Jinhee Ahn, Eun Mi Lee, Yae Min Park, Jun Hyung Kim, Professor Gregory Lip, Hong Euy Lim
Discussion(0)
No comments yet. Be the first to comment.